• Something wrong with this record ?

Mean diameter of nucleolar bodies in cultured human leukemic myeloblasts is mainly related to the S and G2 phase of the cell cycle

K. Smetana, K. Kuzelova, M. Zapotocky, J. Starkova, Z. Hrkal, J. Trka

. 2007 ; 51 (4) : 269-274.

Language English Country Italy

E-resources Online

NLK Free Medical Journals from 2000
ProQuest Central from 2000-01-01 to 2020-06-30
Open Access Digital Library from 2003-01-01
Health & Medicine (ProQuest) from 2000-01-01 to 2020-06-30
ROAD: Directory of Open Access Scholarly Resources from 2000

Mean diameter of nucleolar bodies (nucleoli without the perinucleolar chromatin) per cell was studied in human leukemic myeloblasts represented by K 562 and Kasumi 1 cell lines which originated from chronic and acute myeloid leukaemia. The measurement of mean diameter of nucleolar bodies in specimens stained for RNA was very simple. Such approach eliminated the variability of the perinucleolar chromatin discontinuous shell which might influence the measured nucleolar size as suggested by earlier studies. Ageing of K 562 myeloblasts produced a significant decrease of cells in S+G2 phase of the cell cycle accompanied by a significant reduction of mean diameter of nucleolar bodies (MDNoBs) per cell. In contrast, treatment of Kasumi 1 myeloblasts with histone deacetylase inhibitor - Trichostatin A - produced a large incidence of resistant cells in S+G2 phase which were characterised by a large increase of MDNoBs. Thus, MDNoBs in leukemic myeloblasts might be a helpful tool to estimate the incidence of cells in the S+G2 phase at the single cell level in smear preparations when the number of cells is very small.

000      
00000naa 2200000 a 4500
001      
bmc10025576
003      
CZ-PrNML
005      
20120910175159.0
008      
101014s2007 it e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a it
100    1_
$a Smetana, Karel, $d 1930- $7 nlk19990073860
245    10
$a Mean diameter of nucleolar bodies in cultured human leukemic myeloblasts is mainly related to the S and G2 phase of the cell cycle / $c K. Smetana, K. Kuzelova, M. Zapotocky, J. Starkova, Z. Hrkal, J. Trka
314    __
$a Institute of Hematology and Blood Transfusion, U nemocnice 1, Prague 2, Czech Republic, 128 20 karel.smetana@uhkt.cz.
520    9_
$a Mean diameter of nucleolar bodies (nucleoli without the perinucleolar chromatin) per cell was studied in human leukemic myeloblasts represented by K 562 and Kasumi 1 cell lines which originated from chronic and acute myeloid leukaemia. The measurement of mean diameter of nucleolar bodies in specimens stained for RNA was very simple. Such approach eliminated the variability of the perinucleolar chromatin discontinuous shell which might influence the measured nucleolar size as suggested by earlier studies. Ageing of K 562 myeloblasts produced a significant decrease of cells in S+G2 phase of the cell cycle accompanied by a significant reduction of mean diameter of nucleolar bodies (MDNoBs) per cell. In contrast, treatment of Kasumi 1 myeloblasts with histone deacetylase inhibitor - Trichostatin A - produced a large incidence of resistant cells in S+G2 phase which were characterised by a large increase of MDNoBs. Thus, MDNoBs in leukemic myeloblasts might be a helpful tool to estimate the incidence of cells in the S+G2 phase at the single cell level in smear preparations when the number of cells is very small.
650    _2
$a antigeny jaderné $7 D034961
650    _2
$a počet buněk $7 D002452
650    _2
$a buněčné jadérko $x genetika $x patologie $7 D002466
650    _2
$a proliferace buněk $7 D049109
650    _2
$a G2 fáze $x fyziologie $7 D016195
650    _2
$a prekurzorové buňky granulocytů $x patologie $7 D042381
650    _2
$a lidé $7 D006801
650    _2
$a buňky K562 $7 D020014
650    _2
$a akutní erytroblastická leukemie $x genetika $x patologie $7 D004915
650    _2
$a akutní erytroblastická leukemie $7 D004915
650    _2
$a chronická myeloidní leukemie $x genetika $x patologie $7 D015464
650    _2
$a jaderné proteiny $7 D009687
650    _2
$a organizátor jadérka $x patologie $7 D009697
650    _2
$a RNA nádorová $x analýza $7 D012334
650    _2
$a S fáze $x fyziologie $7 D016196
650    _2
$a financování organizované $7 D005381
700    1_
$a Kuželová, Kateřina $7 xx0115456
700    1_
$a Zápotocký, Michal $7 xx0099530
700    1_
$a Starková, Júlia, $d 1977- $7 xx0106984
700    1_
$a Hrkal, Zbyněk, $d 1934- $7 xx0059987
700    1_
$a Trka, Jan, $d 1966- $7 xx0036261
773    0_
$w MED00001622 $t European journal of histochemistry $g Roč. 51, č. 4 (2007), s. 269-274 $x 1121-760X
910    __
$a ABA008 $b x $y 7
990    __
$a 20101020113629 $b ABA008
991    __
$a 20120910175352 $b ABA008
999    __
$a ok $b bmc $g 800544 $s 665413
BAS    __
$a 3
BMC    __
$a 2007 $b 51 $c 4 $d 269-274 $i 1121-760X $m European journal of histochemistry $n Eur J Histochem $x MED00001622
LZP    __
$a 2010-B/jtme

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...